Brief: Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
22/10/2025 13:14
Oct 22 (Reuters) - Turn Therapeutics Inc TTRX.O: TURN THERAPEUTICS PROVIDES SHAREHOLDER UPDATE HIGHLIGHTING CONTINUED EXECUTION ACROSS CLINICAL AND STRATEGIC MILESTONES Source text: ID:nGNX8ZqjJS Further company coverage: TTRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Turn Therapeutics
See all newsTurn Therapeutics Q2 net loss per share widens on higher R&D costs
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Turn Therapeutics Reports Interim Analysis Findings And Adaptive Optimization Strategy From Phase 2 GX-03 Trial In Moderate-To-Severe Atopic Dermatitis
Brief: Turn Therapeutics Reports First Quarter 2026 Financial Results